Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 408
Book Description
Approved drug products with therapeutic equivalence evaluations 1990 suppl
Approved Prescription Drug Products
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 20
Book Description
Accompanied by supplements.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 20
Book Description
Accompanied by supplements.
Approved Drug Products with Therapeutic Equivalence Evaluations
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Approved Prescription Drug Products with Therapeutic Equivalence Evaluations
Approved Drug Products with Therapeutic Equivalence Evaluations
Approved drug products with therapeutic equivalence evaluations 1995 suppl. | 15th ed., cumulative supplement, Jan. 95-Dec. 95
Approved Prescription Drug Products with Therapeutic Equivalence Evaluations
Author: United States. Food and Drug Administration. Bureau of Drugs
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Approved Prescription Drug Products with Therapeutic Equivalence Evaluations
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 251
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 251
Book Description
Approved Drug Products with Therapeutic Evaluations
Author: DIANE Publishing Company
Publisher: DIANE Publishing
ISBN: 9780788104053
Category :
Languages : en
Pages : 740
Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Composed of 4 parts: approved prescription drug products with therapeutic equivalence evaluations; over-the-counter (OTC) drug products that require approved applications as a condition of marketing; drug products with approval under Sect. 505 of the Act; & products that have never been marketed, have been discontinued from marketing, or that have had their approvals withdrawn for other than safety or efficacy reasons.
Publisher: DIANE Publishing
ISBN: 9780788104053
Category :
Languages : en
Pages : 740
Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Composed of 4 parts: approved prescription drug products with therapeutic equivalence evaluations; over-the-counter (OTC) drug products that require approved applications as a condition of marketing; drug products with approval under Sect. 505 of the Act; & products that have never been marketed, have been discontinued from marketing, or that have had their approvals withdrawn for other than safety or efficacy reasons.
Approved Drug Products with Therapeutic Equivalence Evaluations, 1999
Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0788186795
Category :
Languages : en
Pages : 892
Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.
Publisher: DIANE Publishing
ISBN: 0788186795
Category :
Languages : en
Pages : 892
Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.